BANK OF AMERICA CORP /DE/ - RXI PHARMACEUTICALS CORP NEW ownership

RXI PHARMACEUTICALS CORP NEW's ticker is RXII and the CUSIP is 74979C303. A total of 26 filers reported holding RXI PHARMACEUTICALS CORP NEW in Q4 2015. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
BANK OF AMERICA CORP /DE/ ownership history of RXI PHARMACEUTICALS CORP NEW
ValueSharesWeighting
Q1 2016$5,000
+150.0%
16,000
+166.7%
0.00%
Q4 2015$2,0000.0%6,0000.0%0.00%
Q3 2015$2,000
-33.3%
6,0000.0%0.00%
Q2 2015$3,000
-70.0%
6,000
-57.1%
0.00%
Q1 2015$10,000
-54.5%
14,0000.0%0.00%
Q4 2014$22,000
-21.4%
14,0000.0%0.00%
Q3 2014$28,000
-33.3%
14,0000.0%0.00%
Q2 2014$42,00014,0000.00%
Other shareholders
RXI PHARMACEUTICALS CORP NEW shareholders Q4 2015
NameSharesValueWeighting ↓
Broadfin Capital, LLC 2,252,964$6,804,0000.34%
SPHERA FUNDS MANAGEMENT LTD. 175,815$531,0000.13%
THOMPSON DAVIS & CO., INC. 0$9,0000.01%
Spark Investment Management LLC 11,200$33,0000.01%
Virtu KCG Holdings LLC 55,599$167,0000.00%
Ground Swell Capital, LLC 302$1,0000.00%
JANE STREET GROUP, LLC 62,219$188,0000.00%
Tower Research Capital LLC (TRC) 1,668$5,0000.00%
DIMENSIONAL FUND ADVISORS LP 61$00.00%
AMERICAN INTERNATIONAL GROUP, INC. 11$33,0000.00%
View complete list of RXI PHARMACEUTICALS CORP NEW shareholders